Pfizer licenses Akcea Therapeutics Akcea-AngPtl3-L, an investigational antisense therapy being developed for certain cardiovascular and metabolic dise...
FDA approves a Pfenex Inc. 505(b)(2) NDA for PF708 (teriparatide injection) that referenced Eli Lillys Forteo, indicated for treating osteoporosis.
FDA approves a Galdermas Aklief (trifarotene) Cream for topically treating acne.
FDA grants Mereo BioPharma Group fast track status for navicixizumab and its use for treating high grade ovarian, primary peritoneal or fallopian tube...
FDA clears a ProTom International Holding 510(k) for its Radiance 330 proton therapy system.
FDA Review posts the Federal Register notices for the week ending 10/4/2019.
FDA Review posts product approval summaries for the week ending 10/4/2019.
Federal Register notice: FDA announces an 11/13 Endocrinologic and Metabolic Drugs Advisory Committee meeting to review a Boehringer Ingelheim supplem...